The same ledger reads differently to a board, an employee, and a customer. We assess AI exposure once — and render it for all three.
| Position | Score |
|---|---|
| Document review | M4 |
| Pricing desk | M3 |
| Client onboarding | M2 |
AI exposure assessed, scored, and filed. Fiduciary cover with the AI Act in force.
Price the exposure before the LOI — no cooperation from the target required.
Evidence where the moat actually sits — before the market discounts it.
An evidence-backed AI equity story in every mandate, on one comparable protocol.
Scored M1–M5 like your DD products. Fiduciary cover — "we have assessed AI risk" is a governance expectation with the AI Act in force. Upside priced as options.
The honest version: what changes, what doesn’t, which skills matter next. Most companies communicate nothing — the vacuum fills with LinkedIn doom.
How we use AI, what we don’t do with your data, why our service survives the shift. The ESG report of the 2020s.
The M1–M5 DNA is reused from due diligence: calibrated, comparable across portfolio companies, and defensible in front of an IC.
With the AI Act in force, that sentence is becoming a governance expectation. The exposure statement gives boards fiduciary cover — and once a few companies publish a position statement, their peers' silence becomes conspicuous.
Why now